These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7803638)

  • 1. Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease.
    Hemsell DL; Little BB; Faro S; Sweet RL; Ledger WJ; Berkeley AS; Eschenbach DA; Wölner-Hanssen P; Pastorek JG
    Clin Infect Dis; 1994 Oct; 19(4):720-7. PubMed ID: 7803638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized comparison of gentamicin-clindamycin and cefoxitin-doxycycline in the treatment of acute pelvic inflammatory disease.
    Walters MD; Gibbs RS
    Obstet Gynecol; 1990 May; 75(5):867-72. PubMed ID: 2183112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hospitalized patients with acute pelvic inflammatory disease: comparison of cefotetan plus doxycycline and cefoxitin plus doxycycline.
    Sweet RL; Schachter J; Landers DV; Ohm-Smith M; Robbie MO
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):736-41. PubMed ID: 3162653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of clindamycin/gentamicin and cefoxitin/doxycycline for treatment of pelvic inflammatory disease: a multi-center trial. The European Study Group.
    Acta Obstet Gynecol Scand; 1992 Feb; 71(2):129-34. PubMed ID: 1316041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized comparison of ampicillin-sulbactam to cefoxitin and doxycycline or clindamycin and gentamicin in the treatment of pelvic inflammatory disease or endometritis.
    McGregor JA; Crombleholme WR; Newton E; Sweet RL; Tuomala R; Gibbs RS
    Obstet Gynecol; 1994 Jun; 83(6):998-1004. PubMed ID: 8190448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cefotetan plus doxycycline with cefoxitin plus doxycycline in the inpatient treatment of acute salpingitis.
    Walker CK; Landers DV; Ohm-Smith MJ; Robbie MO; Luft J; Schachter J; Sweet RL
    Sex Transm Dis; 1991; 18(2):119-23. PubMed ID: 1862460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefotaxime, cefoxitin and clindamycin plus gentamicin in the treatment of uncomplicated and complicated pelvic inflammatory disease.
    Martens MG; Faro S; Hammill H; Maccato M; Riddle GD; LaPread E
    J Antimicrob Chemother; 1990 Sep; 26 Suppl A():37-43. PubMed ID: 2228843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation.
    Dodson MG
    J Reprod Med; 1994 Apr; 39(4):285-96. PubMed ID: 8040846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cefoxitin and clindamycin-gentamicin for pelvic infections.
    Larsen JW; Voise CT; Grossman JH
    Clin Ther; 1986; 9(1):77-83. PubMed ID: 3815461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin.
    Thadepalli H; Mathai D; Scotti R; Bansal MB; Savage E
    Obstet Gynecol; 1991 Oct; 78(4):696-702. PubMed ID: 1923175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL; Roy S; Faro S; O'Brien WF; Sanfilippo JS; Seidlin M
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulbactam/ampicillin in the treatment of acute pelvic inflammatory disease.
    Sweet RL; Landers DV; Schachter J; Crombleholme WR
    Suppl Int J Gynecol Obstet; 1989; 2():13-9; discussion 47-8. PubMed ID: 2803578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute pelvic inflammatory disease: comparison of therapeutic protocols].
    Balbi G; Piscitelli V; Di Grazia F; Martini S; Balbi C; Cardone A
    Minerva Ginecol; 1996; 48(1-2):19-23. PubMed ID: 8750486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
    Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease.
    Haggerty CL; Totten PA; Astete SG; Lee S; Hoferka SL; Kelsey SF; Ness RB
    Sex Transm Infect; 2008 Oct; 84(5):338-42. PubMed ID: 18445635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel microbes associated with pelvic inflammatory disease and infertility.
    Haggerty CL; Totten PA; Tang G; Astete SG; Ferris MJ; Norori J; Bass DC; Martin DH; Taylor BD; Ness RB
    Sex Transm Infect; 2016 Sep; 92(6):441-6. PubMed ID: 26825087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pelvic inflammatory disease.
    Peterson HB; Galaid EI; Cates W
    Med Clin North Am; 1990 Nov; 74(6):1603-15. PubMed ID: 2246955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study comparing intravenous meropenem with clindamycin plus gentamicin for the treatment of acute gynecologic and obstetric pelvic infections in hospitalized women.
    Hemsell DL; Martens MG; Faro S; Gall S; McGregor JA
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S222-30. PubMed ID: 9126697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
    Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
    South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
    Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.